Molecular Templates, Inc.MTEM

Market cap
$537.43
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Net loss-------------8
Depreciation, amortization and other5------114777
Loss on disposal of property and equipment0-0--------0-0-0
Change in valuation of contingent value right-------------2
Share Based Compensation40355732461217127
Amortization Of Debt Discount Premium------0000110
Impairment of fixed assets and intangibles-----------0-
Gain on extinguishment of debt--------0--1--2
Accretion of asset retirement obligations-------000000
Prepaid expenses------0104-0-0-1
Grants revenue receivable--------3-7--0
Other assets------000-200-1
Operating lease right-of-use assets and liabilities--------3-00-1-0
Accounts payable2-110-101-210-1-11
Accrued liabilities21100-2037-3-3-1-4
Deferred revenue-6230-15-77-1------42
Net cash used in operating activities-243010-----4-25-84-30-89-42
Purchases of property and equipment60000-16107430
Proceeds from sale of equipment---------0--0
Purchase of marketable securities22494102----1090133211562
Sales of marketable securities20948------6010615315431
Net cash provided by investing activities-9-47-16-----16-40-35-629529
Net Proceeds From Issuance Of Private Placement------------18
Repayment of long-term debt------24-5--28
Proceeds from stock option exercises------0021200
Fees paid on loan modification-----------0-
Net cash used in financing activities232222----49665993-0-9
Net (decrease)/increase in cash, cash equivalents, and restricted cash--------1-60-06-22
Interest Paid Net------0111232
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability-----------5-
Fixed asset additions in accounts payable and accrued expenses--------3100-